HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...

Kennedy says he wants to restore trust in vaccines. His hand-picked ACIP panel raised many doubts, and outside experts were ...

Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taking place from ...

The Cozby Library and Community Commons, in collaboration with the FBI, offer a free seminar on recognizing scams and safeguarding personal data on September 20.

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data from the Phase 2b ANTHEM-UC study with icotrokinra in ulcerative colitis will be the focus of a brief oral ...

Many other school boards in central North Carolina already have some kind of policy or references to a commitment to use it ...

Discover the key insights and breakthroughs from Samsung AI Forum 2025, including agentic AI, LLM reasoning, and generative ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Gandhi said the Karnataka CID wrote 18 times to EC seeking details such as OTP trails and destination ports involved in such deletions but didn't get the info ...

Commissioners voted to delay the landfill expansion after the presentation, and many of the residents in the meeting left ...

Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up? Enrollment for registrational Phase 3 portion of KYSA-6 trial in MG on track to initiate ...